CWC Advisors LLC. Makes New $71,000 Investment in INVO Bioscience, Inc. (NASDAQ:INVO)

CWC Advisors LLC. bought a new stake in shares of INVO Bioscience, Inc. (NASDAQ:INVO) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned 2.64% of INVO Bioscience as of its most recent filing with the Securities and Exchange Commission.

INVO Bioscience Price Performance

NASDAQ INVO opened at $0.84 on Friday. INVO Bioscience, Inc. has a 1-year low of $0.63 and a 1-year high of $3.50. The business’s fifty day moving average price is $0.78 and its 200-day moving average price is $0.87.

INVO Bioscience (NASDAQ:INVO) last posted its earnings results on Wednesday, August 14th. The company reported ($0.62) earnings per share for the quarter. The business had revenue of $1.84 million during the quarter.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.